Advertisement

Topics

Exiqon A/S Company Profile

05:18 EST 21st November 2017 | BioPortfolio

Exiqon A/S focused on the development of novel DNA and immunodiagnostic products against common genetic diseases, in particular, cardiovascular, diabetic and other chronic and degenerative diseases.


News Articles [3 Associated News Articles listed on BioPortfolio]

Exiqon AS Product Pipeline Analysis, 2017 Update [Report Updated: 08062017] Prices from USD $750

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Exiqon AS Medical Equipment Deals and Alliances Profile [Report Updated: 12072017] Prices from USD $250

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Exiqon AS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 22082017] Prices from USD $250

SummaryExiqon A/S Exiqon, a subsidiary of Qiagen NV is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company's product categories include mic...

Drugs and Medications [0 Results]

None

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.

At least seven studies have suggested that microRNA levels in whole blood can be diagnostic for lung cancer. We conducted a large bi-institutional study to validate this. Qiagen® PAXgene™ Blood miR...

A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma.

The differential expression of microRNAs (miRNAs) in plasma of esophageal squamous cell carcinoma (ESCC) patients may serve as a diagnostic biomarker. A four-stage study was conducted to identify plas...

Screening and confirmation of microRNA markers for distinguishing between menstrual and peripheral blood.

The identification of menstrual blood (MB) and peripheral blood (PB) left at a crime scene is crucial for crime reconstruction, especially in sexual assaults. MicroRNAs (miRNAs), a class of non-protei...

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Exiqon

Exiqon operates in two business segments sharing one vision: the idea of taking science to patients through personalized medicine; one focus: the promise of miRNA as biological markers; and one techno...

Exiqon A/S

Exiqon A/S focused on the development of novel DNA and immunodiagnostic products against common genetic diseases, in particular, cardiovascular, diabetic and other chronic and degenerative diseases.

Exiqon A/

Exiqon is the global provider of Locked Nucleic Acid (LNA™) and a leading supplier of high-value gene expression analysis products and web-based software tools to help scientists achieve rapid and r...

More Information about "Exiqon A/S" on BioPortfolio

We have published hundreds of Exiqon A/S news stories on BioPortfolio along with dozens of Exiqon A/S Clinical Trials and PubMed Articles about Exiqon A/S for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Exiqon A/S Companies in our database. You can also find out about relevant Exiqon A/S Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...


Corporate Database Quicklinks



Searches Linking to this Company Record